SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS

被引:0
作者
Neklyudova, G. V. [1 ]
Avdeev, S. N. [1 ]
Tsareva, N. A. [1 ]
Chernyaev, A. L. [1 ]
Samsonova, M. V. [1 ]
Nuumenko, Zh K. [1 ]
Mikhaleva, L. M. [2 ]
机构
[1] Pulmonol Res Inst, Moscow 105077, Russia
[2] Human Morphol Res Inst, Moscow, Russia
关键词
pulmonary hypertension; endothelial dysfunction; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; NITRIC-OXIDE; ARTERIAL-PRESSURE; LUNG; INHALATION; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study morphofunctional condition of pulmonary vessels in chronic obstructive pulmonary disease (CORD) and idiopathic pulmonary fibrosis (IPF), to specify the rule of endothelial dysfunction in pathogenesis of secondary pulmonary hypertension (SPH). Material and methods. Functional examination of cardiovascular and respiratory systems, measurement of systolic pressure (SP) in the pulmonary artery were made in 178 patients: 99 with COPD (8 females and 91 males, mean age 57.2 +/- 9.8 years), 79 with IPF (58 females and 21 mules, mean age 54.1 +/- 12.7 years). The examination has detected echocardiographic signs of pulmonary hypertension (PH). Then 45 PH patients (22 with CORD and 23 with IPF) were tested far vasoreactivity in response to inhalation of O-2, NO in combination with O-2 and iloprost (prostacycline i(2)) with O-2. Next stage of the study was morphometric and immunohistochemical examinations of small brunches of the pulmonary artery (PA). Results. PA SP in COPD patients was 42.8 +/- 11.1 mmHg, in IPF patients - 41.8 +/- 12.6 mmHg. Elevation of PA SP above 35 mmHg was registered in 48.5% patients with COPD and in 43.0% with IPF Patients of both groups responded to a vasodilating impact of inhalatory NO and iloprost while reaction to O-2 inhalation was absent. Morphological study of PA small branches revealed marked changes in the structure of vascular wall which were most manifest in the intima. Conclusion. The findings evidence for an essential role of endothelial dysfunction in formation and progression of PH in pulmonary pathology.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 39 条
[1]   Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease Advances in Pathophysiology and Management [J].
Albert Barbera, Joan ;
Blanco, Isabel .
DRUGS, 2009, 69 (09) :1153-1171
[2]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[3]  
Avtandilov G. G., 1973, MORPHOMETRY PATHOLOG, P248
[4]   Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].
Badesch, DB ;
Abman, SH ;
Ahearn, GS ;
Barst, RJ ;
McCrory, DC ;
Simonneau, G ;
McLaughlin, VV .
CHEST, 2004, 126 (01) :35S-62S
[5]   QUANTITATIVE ASSESSMENT OF PULMONARY-HYPERTENSION IN PATIENTS WITH TRICUSPID REGURGITATION USING CONTINUOUS WAVE DOPPLER ULTRASOUND [J].
BERGER, M ;
HAIMOWITZ, A ;
VANTOSH, A ;
BERDOFF, RL ;
GOLDBERG, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :359-365
[6]   Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension [J].
Carratu P. ;
Scoditti C. ;
Maniscalco M. ;
Seccia T. ;
Di Gioia G. ;
Gadaleta F. ;
Cardone R. ;
Dragonieri S. ;
Pierucci P. ;
Spanevello A. ;
Resta O. .
BMC Pulmonary Medicine, 8 (1)
[7]   IMPAIRMENT OF ENDOTHELIUM-DEPENDENT PULMONARY-ARTERY RELAXATION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE [J].
DINHXUAN, AT ;
HIGENBOTTAM, TW ;
CLELLAND, CA ;
PEPKEZABA, J ;
CREMONA, G ;
BUTT, AY ;
LARGE, SR ;
WELLS, FC ;
WALLWORK, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (22) :1539-1547
[8]   Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemia [J].
Doi, M ;
Nakano, K ;
Hiramoto, T ;
Kohno, N .
RESPIRATORY MEDICINE, 2003, 97 (08) :915-920
[9]  
European Respiratory Society, 2002, Am J Respir Crit Care Med, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]
[10]  
FULMER JD, 1984, CHEST, V86, P234